Study finds 2 new drugs are highly effective in treating Ebola
Preliminary results show that two new Ebola drugs appear to be highly effective when it comes to treating people with the virus.
Scientists studied four experimental drugs, and found that a compound developed by Regeneron Pharmaceuticals and another created by the U.S. National Institutes of Health (NIH) "may be able to improve the survival of people with Ebola," Dr. Anthony Fauci of the NIH told The Associated Press.
The drugs are both antibodies that block the virus, and researchers found a mortality rate of 30 percent for those who received the treatments; the mortality rate for another drug, ZMapp, was 50 percent. When patients received the treatments earlier, mortality rates dropped to 6 percent with the Regeneron drug and 11 percent with the NIH compound, compared to 24 percent with ZMapp.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Over the last year, Ebola has killed more than 1,800 people in Congo, and all treatment centers in the country now have access to these two drugs. "Getting people into care more quickly is absolutely vital," Dr. Michael Ryan of the World Health Organization told AP. "The fact that we have very clear evidence now on the effectiveness of the drugs, we need to get that message out to communities."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Catherine Garcia has worked as a senior writer at The Week since 2014. Her writing and reporting have appeared in Entertainment Weekly, The New York Times, Wirecutter, NBC News and "The Book of Jezebel," among others. She's a graduate of the University of Redlands and the Columbia University Graduate School of Journalism.
-
Magazine solutions - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Magazine printables - December 27, 2024 / January 3, 2025
Puzzles and Quizzes Issue - December 27, 2024 / January 3, 2025
By The Week US Published
-
Why ghost guns are so easy to make — and so dangerous
The Explainer Untraceable, DIY firearms are a growing public health and safety hazard
By David Faris Published
-
Teenage girl kills 2 in Wisconsin school shooting
Speed Read 15-year-old Natalie Rupnow fatally shot a teacher and student at Abundant Life Christian School
By Peter Weber, The Week US Published
-
Penny acquitted in NYC subway choking death
Speed Read Daniel Penny was found not guilty of homicide in the 2023 choking death of Jordan Neely
By Rafi Schwartz, The Week US Published
-
Suspect in CEO shooting caught, charged with murder
Speed Read Police believe 26-year-old Luigi Mangione killed UnitedHealthcare CEO Brian Thompson
By Peter Weber, The Week US Published
-
UnitedHealthcare CEO killed in 'brazen, targeted' hit
Speed Read Police are conducting a massive search for Brian Thompson's shooter
By Rafi Schwartz, The Week US Published
-
DOJ demands changes at 'abhorrent' Atlanta jail
Speed Read Georgia's Fulton County Jail subjects inmates to 'unconstitutional' conditions, the 16-month investigation found
By Rafi Schwartz, The Week US Published
-
China tries to bury deadly car attack
Speed Read An SUV drove into a crowd of people in Zhuhai, killing and injuring dozens — but news of the attack has been censored
By Peter Weber, The Week US Published
-
Menendez brothers may go free in LA prosecutor plan
Speed Read Prosecutors are asking for the brothers to be resentenced for the 1989 murder of their parents
By Peter Weber, The Week US Published
-
Abercrombie ex-CEO charged with sex crimes
Speed Read Mike Jeffries ran the brand during its heyday from 1992 to 2014
By Rafi Schwartz, The Week US Published